Stock Price
204.40
Daily Change
-1.40 -0.68%
Monthly
0.77%
Yearly
0.90%
Q3 Forecast
202.06


Peers Price Chg Day Year Date
Cspc Pharmaceutical 11.13 -0.35 -3.05% 144.08% Sep/09
Avita Medical 1.31 -0.03 -2.25% -50.38% Sep/09
Sh Fosun Pharma 32.02 -0.06 -0.19% 43.33% Sep/09
Jiangsu Hengrui 71.36 -0.95 -1.31% 60.18% Sep/09
Zhangzhou Pientzehuang Pharmaceutical 204.40 -1.40 -0.68% 0.90% Sep/09
Kangmei Pharma 2.02 -0.02 -0.98% 14.77% Sep/09
WuXi AppTec 105.58 -5.02 -4.54% 183.13% Sep/09
Tectonic Therapeutic 16.31 -0.49 -2.92% -7.64% Sep/08
Ionis Pharmaceuticals 61.00 -0.23 -0.38% 26.22% Sep/08
IQVIA Holdings 187.68 0.00001 0% -22.08% Sep/08
Dianthus Therapeutics 31.80 5.30 20.00% 14.18% Sep/08
Moderna 24.83 -0.31 -1.23% -67.60% Sep/08
Revvity 86.28 -0.36 -0.42% -27.33% Sep/08
Viatris 10.48 -0.02 -0.19% -5.76% Sep/08
Xeris Pharmaceuticals 7.77 -0.08 -1.02% 191.01% Sep/08
Alaunos Therapeutics 2.19 0.03 1.39% -3.10% Sep/08

Indexes Price Day Year Date
SHANGHAI 50 2925 -14.83 -0.50% 30.83% Sep/09

Zhangzhou Pientzehuang Pharmaceutical Co Ltd traded at 204.40 this Tuesday September 9th, decreasing 1.40 or 0.68 percent since the previous trading session. Looking back, over the last four weeks, Zhangzhou Pientzehuang Pharmaceutical lost 0.77 percent. Over the last 12 months, its price rose by 0.90 percent. Looking ahead, we forecast Zhangzhou Pientzehuang Pharmaceutical Co Ltd to be priced at 202.06 by the end of this quarter and at 196.71 in one year, according to Trading Economics global macro models projections and analysts expectations.